tiprankstipranks
Trending News
More News >
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market

Aquestive Therapeutics (AQST) Revenue

Compare
2,173 Followers

Aquestive Therapeutics Revenue

Aquestive Therapeutics had a revenue of 8.72M in the quarter ending Mar 31, 2025, with -26.52%. This bring the company's revenue in the last twelve months to 54.23M, Increased -5.79%. In the fiscal year ending Dec 31, 2024, Aquestive Therapeutics had annual revenue of 57.56M with 13.80% growth.
Revenue (ttm)
54.23M
Revenue Growth
5.29%
P/S Ratio
6.18
Revenue/Employee
$405,359
Employees
142
Market Cap
$355.59M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
57.56M6.98M+13.80%
Dec 31, 2023
50.58M2.90M+6.09%
Dec 31, 2022
47.68M-3.15M-6.20%
Dec 31, 2021
50.83M4.98M+10.87%
Dec 31, 2020
45.85M-6.76M-12.85%
Dec 31, 2019
52.61M-14.82M-21.98%
Dec 31, 2018
67.43M512.00K+0.77%
Dec 31, 2017
66.92M15.13M+29.22%
Dec 31, 2016
51.78M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis